A global mpox vaccine store has opened. Here is what it does
What happened
On 2 September 2026, the World Health Organization announced that a global mpox vaccine stockpile had been launched. A stockpile is exactly what it sounds like. It is a store of vaccine doses held ready, so that when an outbreak starts somewhere, doses can be sent quickly instead of being argued over. The store was set up on 27 August. It is funded by Gavi, the Vaccine Alliance, and coordinated by a group called the International Coordinating Group on Vaccine Provision. That group brings together four organisations: the International Federation of Red Cross and Red Crescent Societies, Medecins Sans Frontieres, UNICEF and WHO. The idea is simple and it is not new. The same four partners already run shared stores for other diseases. What is new is that mpox now has one of its own, with a long-term home rather than a temporary arrangement. The stockpile builds on a mechanism created in 2024, during the last time mpox was declared a public health emergency of international concern. That earlier arrangement was put together in a hurry. This one is meant to sit there permanently, ready. Dr Sania Nishtar, chief executive of Gavi, put the aim plainly: 'Any country in the world should be able to use this tool to save lives.'
Why this matters
During the 2024 mpox emergency, one of the loudest complaints was not that vaccines did not exist. It was that the countries with the most cases were at the back of the queue. When doses have to be found, negotiated and paid for after an outbreak has already started, weeks are lost. In an outbreak, weeks are not an administrative delay. They are more cases and more deaths. A standing stockpile changes the order of events. The doses are already bought and already sitting somewhere. A country that needs them applies to the coordinating group, and the doses move. The part that matters most is the promise that access does not depend on ability to pay. That is the difference between a global supply and a market. For readers in the UK, the direct risk from mpox remains low, and this is not a story about a threat on your doorstep. It matters for a different reason. Outbreaks that are contained abroad do not become outbreaks that travel.
What the evidence actually says
It is worth being careful about what has and has not been announced. What is confirmed is the mechanism: who funds it, who runs it, and the principle that doses go where they are needed regardless of a country's wealth. WHO's announcement names Gavi as the funder and the International Coordinating Group as the coordinator, with IFRC, MSF, UNICEF and WHO as its partners. What WHO's announcement does not set out is a headline number of doses or a total budget figure. So anyone quoting you a precise size for this stockpile is going beyond what has been published. It is also worth being realistic about what a stockpile can and cannot do. It solves supply and allocation. It does not solve the harder problems: getting doses from an airport to a rural clinic, keeping them cold on the way, finding the health workers to give them, and persuading people to come forward. Stockpiles have a good track record for diseases such as yellow fever, cholera and meningitis, where the same shared model is already used. That is the reason to be cautiously positive here. It is a model that has worked before, applied to a disease that needed it.
Practical advice
For most people in the UK, there is nothing you need to do differently because of this announcement. If you are travelling to a country with a current mpox outbreak, the sensible step is the ordinary one: check the travel health advice for your destination before you book, and again a few weeks before you go, because it changes. Your GP practice, a travel clinic or your pharmacist can talk you through what is recommended for where you are going. If you are in a group that the NHS already offers mpox vaccination to, and you have been putting it off, this is a reasonable moment to book it. More generally, this is a good reminder to keep your routine vaccinations up to date. Outbreak news tends to arrive suddenly. Being already protected is far easier than catching up in a hurry. And if you read alarming claims about mpox online, check them against WHO or the UK Health Security Agency before passing them on. Outbreak stories attract a lot of noise.
What to know
A permanent global store of mpox vaccines now exists, funded by Gavi and run by the same partnership that already manages shared vaccine stores for several other diseases. Its purpose is speed and fairness: doses ready in advance, and available to countries whether or not they can pay. It does not remove the hard work of actually delivering vaccines on the ground, and no dose figures have been published. But it is a sensible, unglamorous piece of preparation, and preparation is usually what makes the difference when the next outbreak starts. Sources: World Health Organization, 'Global initiative launched to improve access to mpox vaccines', 2 September 2026, https://www.who.int/news/item/02-09-2026-global-initiative-launched-to-improve-access-to-mpox-vaccines ; UNICEF, 'Global initiative launched to improve access to mpox vaccines', 2 September 2026, https://www.unicef.org/press-releases/global-initiative-launched-improve-access-mpox-vaccines This article is for general information and does not replace advice from a doctor, pharmacist or other qualified healthcare professional. If you are travelling abroad, check current travel health advice for your destination before you go.
Related articles
Free finger-prick kits that tell you your blood type
NHS Blood and Transplant has started giving away free kits that let you find out your own blood type at home. The scheme was announced on 2 September 2026. Up…
The shingles jab and your heart: what new research found
New research suggests the modern shingles vaccine may do more than prevent shingles. It may also be linked to less heart disease. The study was published in th…
A common prostate and ED medicine is linked to higher glaucoma risk
A large study has linked long-term use of the medicine tadalafil to a higher chance of developing glaucoma, an eye condition that can steal your sight without w…